Format
Sort by
Items per page

Send to

Choose Destination

Best matches for carbamazepine bipolar:

Carbamazepine. Alrashood ST et al. Profiles Drug Subst Excip Relat Methodol. (2016)

Targeting astrocytes in bipolar disorder. Peng L et al. Expert Rev Neurother. (2016)

Relationships between pharmacokinetic parameters of carbamazepine and therapeutic response in patients with bipolar disease. Chbili C et al. Ann Biol Clin (Paris). (2014)

Search results

Items: 1 to 20 of 1383

1.

An Interesting Case of Carbamazepine-Induced Stevens-Johnson Syndrome.

Masuka JT, Muzopambwa G, Khoza S, Chibanda D.

Drug Saf Case Rep. 2018 Dec 10;6(1):1. doi: 10.1007/s40800-018-0095-y.

PMID:
30535610
2.

Patient Survival After Acute Voluntary Poisoning With a Huge Dose of Oxcarbazepine and Olanzapine.

Kalogera V, Galopoulos D, Eleftheriotis G, Meimeti E, Malios I, Marathonitis G, Loupa C.

Med Arch. 2018 Oct;72(4):303-305. doi: 10.5455/medarh.2018.72.303-305.

3.

[The relationship between intake of lithium and neuroradiological alterations in bipolar disorder. Are there predictors of clinical remission?]

Hamm C, Queissner R, Pilz R, Birner A, Platzer M, Fellendorf F, Maget A, Bengesser S, Dalkner N, Reininghaus B, Reininghaus E.

Fortschr Neurol Psychiatr. 2018 Nov 19. doi: 10.1055/a-0637-1820. [Epub ahead of print] German.

PMID:
30453335
4.

Use of antiepileptic mood stabilizers in dermatology.

Gupta MA, Pur DR, Vujcic B, Gupta AK.

Clin Dermatol. 2018 Nov - Dec;36(6):756-764. doi: 10.1016/j.clindermatol.2018.08.005. Epub 2018 Aug 16.

PMID:
30446200
5.

Illness and drug modifiable factors associated with violent behavior in homeless people with severe mental illness: results from the French Housing First (FHF) program.

Fond G, Boyer L, Boucekine M, Girard V, Loubière S, Lenoir C, Auquier P, Tinland A; French Housing First Study Group.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Nov 10;90:92-96. doi: 10.1016/j.pnpbp.2018.11.006. [Epub ahead of print]

PMID:
30423419
6.

Bipolar Disorder Mixed Episodes: A Pragmatic Trial of a Public Health Treatment Effectiveness.

Miguel SRPS, Lima AFBS, Cruz LN, Cohen M, Zimmermann JJ, Ziegelmann PK, Fleck MPA.

Value Health Reg Issues. 2018 Oct 10;17:158-163. doi: 10.1016/j.vhri.2018.07.004. [Epub ahead of print]

PMID:
30316147
7.

Lithium, valproate, and carbamazepine prescribing patterns for long-term treatment of bipolar I and II disorders: A prospective study.

Musetti L, Tundo A, Benedetti A, Massimetti G, Cambiali E, Pergentini I, Del Grande C, Dell'Osso L.

Hum Psychopharmacol. 2018 Nov;33(6):e2676. doi: 10.1002/hup.2676. Epub 2018 Oct 12.

PMID:
30311959
8.

Mood stabilisers and risk of stroke in bipolar disorder.

Chen PH, Tsai SY, Pan CH, Chang CK, Su SS, Chen CC, Kuo CJ.

Br J Psychiatry. 2018 Oct 8:1-6. doi: 10.1192/bjp.2018.203. [Epub ahead of print]

PMID:
30295208
9.

Pharmacotherapy of Down syndrome.

Palumbo ML, McDougle CJ.

Expert Opin Pharmacother. 2018 Sep 26:1-15. doi: 10.1080/14656566.2018.1529167. [Epub ahead of print]

PMID:
30257591
10.

Major Congenital Malformations Associated With Exposure to Antiepileptic Drugs During Pregnancy.

Andrade C.

J Clin Psychiatry. 2018 Jul 17;79(4). pii: 18f12449. doi: 10.4088/JCP.18f12449.

11.

Nociceptin/orphanin FQ receptor agonists increase aggressiveness in the mouse resident-intruder test.

Silva EF, Silva AI, Asth L, Souza LS, Zaveri NT, Guerrini R, Calo' G, Ruzza C, Gavioli EC.

Behav Brain Res. 2019 Jan 1;356:120-126. doi: 10.1016/j.bbr.2018.08.019. Epub 2018 Aug 22.

PMID:
30142397
12.

Treatment of Peripartum Bipolar Disorder.

Clark CT, Wisner KL.

Obstet Gynecol Clin North Am. 2018 Sep;45(3):403-417. doi: 10.1016/j.ogc.2018.05.002. Review.

PMID:
30092918
13.

Weight changes associated with antiepileptic mood stabilizers in the treatment of bipolar disorder.

Grootens KP, Meijer A, Hartong EG, Doornbos B, Bakker PR, Al Hadithy A, Hoogerheide KN, Overmeire F, Marijnissen RM, Ruhe HG.

Eur J Clin Pharmacol. 2018 Nov;74(11):1485-1489. doi: 10.1007/s00228-018-2517-2. Epub 2018 Aug 7. Erratum in: Eur J Clin Pharmacol. 2018 Sep 14;:.

PMID:
30083876
14.

Carbamazepine Therapy and HLA Genotype.

Dean L.

In: Pratt V, McLeod H, Rubinstein W, Dean L, Kattman B, Malheiro A, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012-.
2015 Oct 14 [updated 2018 Aug 1].

15.

A History of the Pharmacological Treatment of Bipolar Disorder.

López-Muñoz F, Shen WW, D'Ocon P, Romero A, Álamo C.

Int J Mol Sci. 2018 Jul 23;19(7). pii: E2143. doi: 10.3390/ijms19072143. Review.

16.

Regulation of Glycogen Content in Astrocytes via Cav-1/PTEN/AKT/GSK-3β Pathway by Three Anti-bipolar Drugs.

Jia S, Li B, Huang J, Verkhratsky A, Peng L.

Neurochem Res. 2018 Aug;43(8):1692-1701. doi: 10.1007/s11064-018-2585-9. Epub 2018 Jul 2.

PMID:
29968232
17.

Therapeutic Drug Monitoring of Antiepileptic Drugs in Epilepsy: A 2018 Update.

Patsalos PN, Spencer EP, Berry DJ.

Ther Drug Monit. 2018 Oct;40(5):526-548. doi: 10.1097/FTD.0000000000000546.

PMID:
29957667
18.

Antiepileptic drugs and suicide-related outcomes in bipolar disorder: A descriptive review of published data.

Caley CF, Perriello E, Golden J.

Ment Health Clin. 2018 Apr 26;8(3):138-147. doi: 10.9740/mhc.2018.05.138. eCollection 2018 May.

19.

Carbamazepine Toxicity.

Al Khalili Y, Murphy PB.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-.
2018 Oct 27.

20.

Magnesium in psychoses (schizophrenia and bipolar disorders).

Nechifor M.

In: Vink R, Nechifor M, editors. Magnesium in the Central Nervous System [Internet]. Adelaide (AU): University of Adelaide Press; 2011.

Supplemental Content

Loading ...
Support Center